- Email: [email protected]
Targeting the mouse genome: a compendium of knockouts (part III)
E.P. BRANDON, R.L. IDZERDA AND G.S. MCKNIGHT
KNOCKOUTS
Targeting the mouse genome: a compendium of knockouts (part III)
© Current Biology 1995, Vol 5 No 8
873
874
Current Biology 1995, Vol 5 No 8
KNOCKOUTS
875
876
Current Biology 1995, Vol 5 No 8
KNOCKOUTS
877
878
Current Biology 1995, Vol 5 No 8 References 398. Cremer H, Lange R, Christoph A, Plomann M, Vopper G, Roes J, et al.: Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature
422.
1994, 367:455-459.
399. Tomasiewicz H, Ono K, Yee D, Thompson C, Goridis C, Rutishauser U, et al.: Genetic deletion of a neural cell adhesion molecule variant (N-CAM-180) produces distinct defects in the central nervous system. Neuron 1993, 11:1163-1174.
400. Brannan Cl, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, et a.: Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994, 8:1019-1029. 401. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumour predisposition in mice heterozygous for a targeted mutation in Nfl. Nature Genet 1994, 7:353-361. 402. Ernfors P, Lee KF, Kucera J, Jaenisch R: Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994, 77:503-512. 403. Tessarollo L, Vogel KS, Palko ME, Reid SW, Parada LF: Targeted
mutation in the neurotrophin-3 gene results in loss of muscle sensory neurons. Proc Natl Acad Sci USA 1994, 91:11844-11848. 404. Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF: Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994, 369:658-661. 405. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, et al.: Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995, 80:353-361.
406. Sha WC, Liou H-C, Tuomanen El, Baltimore D: Targeted disruption of the p50 subunit of NF-kappaB leads to multifocal defects in immune responses. Cell 1995, 80:321-330. 407. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993, 75:1273-1286. 408. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994, 265:1883-1885. 409. O'Dell Ti, Huang PL, Dawson TM, Dinerman JL, Snyder SH, Kandel ER, et a.: Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 1994, 265: 542-546. 410. Swiatek PJ,Lindsell CE, del AFF, Weinmaster G, Gridley T: Notch1 is essential for postimplantation development in mice. Genes Dev 1994, 8:707-719. 411. Corcoran LM, Karvelas M, Nossal GJ, Ye ZS, Jacks T, Baltimore D: Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev 1993, 7:570-582.
412. Pollock JD, Williams DA, Gifford MAC, Li LL, Du X, Fisherman Ji,et al.: Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nature Genet 1995, 9:202-209. 413. Giese KP, Martini R, Lemke G, Soriano P, Schachner M: Mouse PO gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 1992, 71:565-576.
414. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CAJ, Butel JS, et al.: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356:
423. 424.
425. 426. 427. 428. 429. 430. 431.
432. 433.
434.
435. 436. 437. 438. 439.
215-221.
415. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992, 70:923-935. 416. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, et al.: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993, 362:849-852. 417. Harvey M, McArthur MJ, Montgomery CAJ, Butel JS, Bradley A, Donehower LA: Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet 1993, 5:225-229. 418. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, et al.: In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 1993, 8:2457-2467. 419. Hursting SD, Perkins SN, Phang JM: Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc Natl Acad Sci USA 1994, 91:7036-7040. 420. Kemp Ci, Donehower LA, Bradley A, Balmain A: Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 1993, 74:813-822.
421. Kemp CJ, Wheldon T, Balmain A: p53-deficient mice are extremely
440. 441. 442.
443.
444. 445.
susceptible to radiation-induced tumorigenesis. Nature Genet 1994, 8:66-69. Lee JM, Abrahamson J, Kandel R, Donehower LA, Bernstein A: Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 1994, 9: 3731-3736. Lotem J, Sachs L: Hematopoietic cells from mice deficient in wildtype p53 are more resistant to induction of apoptosis by some agents. Blood 1993, 82:1092-1096. Berges RR, Furuya Y, Remington L, English HF, Jacks T, Isaacs JT: Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 1993, 90:8910-8914. Kastan MB, Zhan Q, El-Deiry WS, Carrier F,Jacks T, Walsh WV, et a.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 isdefective inataxia-telangiectasia. Cell 1992, 71: 587-597. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993, 74:957-967. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993, 362:847-849. Lowe SW, Jacks T, Housman DE, Ruley HE: Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA 1994, 91:2026-2030. Symonds H, Krall L, Remington L, Saenz RM, Lowe S, Jacks T, et al.: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994, 78:703-711. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994, 371:72-74. Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH: p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 1994, 9:1767-1773. Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SE,etal.: Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 1994, 9:603-609. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, et al.: Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 1994, 8:277-289. Lowin B, Beermann F, Schmidt A, Tschopp J: A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994, 91: 11571-11575. Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, et al.: Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA 1994, 91:10854-10858. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ,etal.: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994, 369:31-37. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994, 370:650-652. Laird PW, van der Lugt NMT, Clarke A, Domen J, Linders K, McWhir J, et al.: In vivo analysis of Pim-1 deficiency. Nucleic Acids Res 1993, 21:4750-4755. Domen J, van der Lugt NMT, Acton D, Laird PW, Linders K, Berns A: Pim-1 levels determine the size of early B lymphoid compartments in bone marrow. J Exp Med 1993, 178:1665-1673. Domen J, van der Lugt NMT, Laird PW, Saris CJ, Berns A: Analysis of Pim-1 function in mutant mice. Leukemia 1993, 7 (suppl 2): 108-112. Domen J, van der Lugt NMT, Laird PW, Saris CJ, Clarke AR, Hooper ML, et al.: Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells. Blood 1993, 82:1445-1452. Carmeliet P, Kieckens L, Schoonjans L, Ream B, van NA, Prendergast G, et al.: Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest 1993, 92:2746-2755. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van dOJJ, De MM, et al.: Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. Clin Invest 1993, 92:2756-2760. Leveen P, Pekny M, Gebre MS, Swolin B, Larsson E, Betsholtz C: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 1994, 8:1875-1887. Soriano P: Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 1994, 8: 1888-1896.
KNOCKOUTS 446. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al.: Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992, 356:577-582. 447. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al.: Mice devoid of PrP are resistant to scrapie. Cell 1993, 73: 1339-1347. 448. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, et al.: Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 1993, 90:10608-10612. 449. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, et al.: Prion protein is necessary for normal synaptic function. Nature 1994, 370:295-297. 450. Weissmann C, Bueler H, Fischer M, Aguet M: Role of the PrP gene in transmissible spongiform encephalopathies. Intervirology 1993, 35:164-175. 451. Weissmann C, Bueler H, Fischer M, Sauer A, Aguet M: Susceptibility to scrapie in mice is dependent on PrPC. Philos Trans R Soc Lond [Bioll] 1994, 343:431-433. 452. Sailer A, Bueler H, Fischer M, Aguzzi A, Weissmann C: No propagation of prions in mice devoid of PrP. Cell 1994, 77:967-968. 453. Whittington MA, Sidle KCL, Gowland I, Meads J, Hill AF, Palmer MS, et al.: Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nature Genet 1995, 9:197-201. 454. Abeliovich A, Paylor R, Chen C, Kim JJ,Wehner JM, Tonegawa S: PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning. Cell 1993, 75:1263-1271. 455. Abeliovich A, Chen C, Goda Y, Silva A], Stevens CF, Tonegawa S: Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell 1993, 75:1253-1262. 456. Boison D, Stoffel W: Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci USA 1994, 91:11709-11713. 457. Scott EW, Simon MC, Anastasi J, Singh H: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994, 265:1573-1577. 458. Geppert M, Bolshakov VY, Siegelbaum SA, Takei K, De CP, Hammer RE, et al.: The role of Rab3A in neurotransmitter release. Nature 1994, 369:493-497. 459. Umanoff H, Edelmann W, Pellicer A, Kucherlapati R: The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci USA 1995, 92:1 709-1713. 460. Warren AJ, Colledge WH, Carlton MB, Evans Mi, Smith AJ, Rabbitts TH: The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 1994, 78:45-57. 461. Mombaerts P,-lacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877. 462. Spanopoulou E, Roman CA, Corcoran LM, Schlissel MS, Silver DP, Nemazee D, et al.: Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev 1994, 8:1030-1042. 463. Levelt CN, Mombaerts P, Iglesias A, Tonegawa S, Eichmann K: Restoration of early thymocyte differentiation in T-cell receptor betachain-deficient mutant mice by transmembrane signaling through CD3 epsilon. Proc Natl Acad Sci USA 1993, 90:11401-11405. 464. Lafaille JJ,Nagashima K, Katsuki M, Tonegawa S: High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994, 78:399-408. 465. Mombaerts P,Clarke AR, Rudnicki MA, lacomini J, Itohara S, Lafaille JJ, et al.: Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages [published erratum appears in Nature 1992; 360:4911. Nature 1992, 360:225-231. 466. Godfrey DI, Kennedy J, Mombaerts P, Tonegawa S, Zlotnik A: Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8- thymocyte differentiation. J Immunol 1994, 152:4783-4792. 467. Jacobs H, Vandeputte D, Tolkamp L, de Vries E, Borst J, Berns A: CD3 components at the surface of pro-T cells can mediate pre-T cell development in vivo. Eurl Immunol 1994, 24:934-939. 468. Shinkai Y, Rathbun C, Lam KP, Oltz EM, Stewart V, Mendelsohn M, et al.: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867. 469. Chen J, Lansford R, Stewart V, Young F, Alt FW: RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. Proc Natl Acad Sci USA 1993, 90:4528-4532. 470. Rodewald HR, Awad K, Moingeon P, D'Adamio L, Rabinowitz D, Shinkai Y, et al.: Fc gamma RII/111 and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes:
in vivo developmental kinetics and T cell receptor beta chain rearrangement status. J Exp Med 1993, 177:1079-1092. 471. Bottaro A, Lansford R, Xu L, Zhang J, Rothman P, Alt FW: S region transcription per se promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO J 1994, 13:665-674. 472. Shinkai Y, Koyasu S, Nakayama K, Murphy KM, Loh DY, Reinherz EL, et al.: Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science 1993, 259:822-825. 473. Castigli E,Alt FW, Davidson L, Bottaro A, Mizoguchi E,Bhan AK, et al.: CD40-deficient mice generated by recombination-activating gene-2deficient blastocyst complementation. Proc Natl Acad Sci USA 1994, 91:12135-12139. 474. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck R-P, et al.: Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappaB/Rel family. Cell 1995, 80:331-340. 475. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, et al.: Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995, 373:531-536. 476. Schuchardt A, D'Agati V, Larsson BL, Costantini F, Pachnis V: Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994, 367:380-383. 477. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA: Effects of an Rb mutation in the mouse. Nature 1992, 359: 295-300. 478. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, et al.: Requirement for a functional Rb-i gene in murine development. Nature 1992, 359:328-330. 479. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, et al.: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992, 359:288-294. 480. Hu N, Gutsmann A, Herbert DC, Bradley A, Lee WH, Lee EY: Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 1994, 9:1021-1027. 481. Lee EY, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, et a.: Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev 1994, 8:2008-2021. 482. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub MP, et al.: High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci USA 1993, 90:7225-7229. 483. Li E, Sucov HM, Lee KF, Evans RM, aenisch R: Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. Proc Natl Acad Sci USA 1993, 90:1590-1594. 484. Mendelsohn C, Mark M, Dolle P, Dierich A, Gaub MP, Krust A, et al.: Retinoic acid receptor beta2 (RARbeta2) null mutant mice appear normal. Dev Biol 1994, 166:246-258. 485. Lohnes D, Kastner P Dierich A, Mark M, LeMeur M, Chambon P: Function of retinoic acid receptor gamma in the mouse. Cell 1993, 73:643-658. 486. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, Evans RM: RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 1994, 8:1007-1018. 487. Kastner P,Grondona JM, Mark M, Gansmuller A, LeMeur M, Decimo D, et a: Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 1994, 78:987-1003. 488. Takeshima H, lino M, Takekura H, Nishi M, Kuno J, Minowa O, et al.: Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 1994, 369:556-559. 489. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD: Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993, 74:541-554. 490. Saudou F,Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L, et al.: Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 1994, 265:1875-1878. 491. Luo X, Ikeda Y, Parker KL: A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490. 492. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, Nachtigal MW, et al.: The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 1994, 8:2302-2312. 493. Jung S, Rajewsky K, Radbruch A: Shutdown of class switch recombination by deletion of a switch region control element. Science 1993, 259:984-987. 494. Soriano P, Montgomery C, Geske R, Bradley A: Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991, 64:693-702.
879
880
Current Biology 1995, Vol 5 No 8 495. Thomas JE,Soriano P, Brugge JS: Phosphorylation of c-Src on tyrosine 527 by another protein tyrosine kinase. Science 1991, 254: 568-571. 496. Boyce BF, Chen H, Soriano P, Mundy GR: Histomorphometric and immunocytochemical studies of src-related osteopetrosis. Bone 1993, 14:335-340. 497. Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P: Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA 1993, 90:4485-4489. 498. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ: Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 1994, 8:23-32. 499. Thomas JE, Aguzzi A, Soriano P, Wagner EF, Brugge IS: Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. Oncogene 1993, 8:2521-2529. 500. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR: Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 1992, 90:1622-1627. 501. Kohmura N, Yagi T, Tomooka Y, Oyanagi M, Kominami R,Takeda N, et al.: A novel nonreceptor tyrosine kinase, Srm: Cloning and targeted disruption. Mol Cell Biol 1994, 14:6915-6925. 502. Rosahl TW, Geppert M, Spillane D, Herz J, Hammer RE, Malenka RC, et al.: Short-term synaptic plasticity is altered in mice lacking synapsin I. Cell 1993, 75:661-670. 503. Geppert M, Goda Y, Hammer RE, Li C, Rosahl TW, Stevens CF, et 2 al.: Synaptotagmin I:a major Ca +sensor for transmitter release at a central synapse. Cell 1994, 79:717-727. 504. Verbeek S, Izon D, Hofhuis F, Robanus-Maandag E, te Riele H, van de Wetering M, et al.: An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 1995, 374:70-74. 505. Philpott KL, Viney JL, Kay G, Rastan S, Gardiner EM, Chae S, et al.: Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. Science 1992, 256:1448-1452. 506. Mombaerts P, Arnoldi , Russ F, Tonegawa S, Kaufmann SH: Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature 1993, 365:53-56. 507. Tsuji M, Mombaerts P, Lefrancois L, Nussenzweig RS, Zavala F, Tonegawa S: Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. Proc Natl Acad Sci USA 1994, 91:345-349. 508. Wen L, Roberts SJ,Viney JL, Wong FS,Mallick C, Findly RC, et al.: Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cells. Nature 1994, 369:654-658. 509. Viney JL, Dianda L, Roberts SJ,Wen L, Mallick CA, Hayday AC, et al.: Lymphocyte proliferation in mice congenitally deficient in T+ cell receptor alphabeta cells. Proc Natl Acad Sci USA 1994, 91:11948-11952. 510. Itohara S, Mombaerts P, Lafaille J, lacomini J, Nelson A, Clarke AR, et al.: T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell 1993, 72:337-348. 511. Ohno H, Goto S, Taki S, Shirasawa T, Nakano H, Miyatake S, et al.: Targeted disruption of the CD3 eta locus causes high lethality in mice: modulation of Oct-1 transcription on the opposite strand. EMBOJ 1994, 13:1157-11565. 512. Koyasu S, Hussey RE, Clayton LK, Lerner A, Pedersen R, Delany HP, et al.: Targeted disruption within the CD3 zeta/eta/phi/Oct-1 locus in mouse. EMBOJ 1994, 13:784-797. 513. Love PE, Shores EW, Johnson MD, Tremblay ML, Lee EJ,Grinberg A, et al.: T cell development in mice that lack the zeta chain of the T cell antigen receptor complex. Science 1993, 261:918-921. 514. Liu C-P, Ueda R, She I, Sancho J, Wang B, Weddell G, et a/.: Abnormal T cell development in CD3-zeta-/- mutant mice and identification of a novel T cell population in the intestine. EMBO 1993, 12:4863-4875. 515. Ohno H, Aoe T, Taki S, Kitamura D, Ishida Y, Rajewsky K, et al.: Developmental and functional impairment of T cells in mice lacking CD3 zeta chains. EMBOJ 1993, 12:4357-4366. 516. Shores EW, Huang K, Tran T, Lee E, Grinberg A, Love PE: Role of TCR zeta chain in T cell development and selection. Science 1994, 266:1047-1050. 517. Malissen M, Gillet A, Rocha B, Trucy , Vivier E, Boyer C, et al.: T cell development in mice lacking the CD3-zeta/eta gene. EMBO J 1993, 12:4347-4355. 518. Shivdasani RA, Mayer EL, Orkin SH: Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature 1995, 373:432-434. 519. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, et al.: Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 1994, 369:488-491.
520. Dumont DJ, Gradwohl G, Fong GH, Purl MC, Gertsenstein M, Auerbach A, et al.: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994, 8: 1897-1909. 521. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S: Mice develop normally without tenascin. Genes Dev 1992, 6:1821-1831. 522. Steindler DA, Settles D, Erickson HP, Laywell ED, Yoshiki A, Faissner A, et al.: Tenascin knockout mice: barrels, boundary molecules, and glial scars. J Neurosci 1995, 15:1971-1983. 523. Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D: Mice lacking TdT: mature animals with an immature lymphocyte repertoire Published erratum appears in Science 1993; 262:1957]. Science 1993, 261:1175-1178. 524. Healy AM, Rayburn HB, Rosenberg RD, Weiler H: Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci USA 1995, 92:850-854. 525. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, et al.: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994, 368:419-424. 526. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, et a.: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993, 90:770-774. 527. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ,Yin M, et al.: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693 699. 528. Christ M, McCartney-Francis NL, Kulkarni AB, Ward IM, Mizel DE, Mackall CL, et al.: Immune dysregulation in TGF-beta 1-deficient mice. J Immunol 1994,153:1936-1946. 529. Geiser AG, Letterio J, Kulkarni AB, Karlsson S, Roberts AB, Sporn MB: Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc Natl Acad Sci USA 1993, 90:9944-9948. 530. Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, et al.: Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci USA 1993, 90:6076-6080. 531. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB: Maternal rescue of transforming growth factor-beta 1 null mice. Science 1994, 264:1936-1938. 532. Glick AB, Lee MM, Darwiche N, Kulkarni AB, Karlsson S, Yuspa SH: Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes Dev 1994, 8:2429-2440. 533. Hines KL, Kulkarni AB, McCarthy JB, Tian H, Ward JM, Christ M, et al.: Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc Natl Acad Si USA 1994, 91:5187-5191. 534. Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S: TAP1 mutant mice are deficient in antigen presentation, surface class I + molecules, and CD4-8 T cells. Cell 1992, 71:1205-1214. 535. Ashton-Rickardt PG, Bandeira A, Delaney JR, Van Kaer L, Pircher HP, Zinkernagel RM, et al.: Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994, 76:651-663. 536. Moriwaki S, Korn BS, Ichikawa Y, Van Kaer L, Tonegawa S: Amino acid substitutions in the floor of the putative antigen-binding site of H-2T22 affect recognition by a gamma delta T-cell receptor. Proc Natl Acad Sci USA 1993, 90:11396-11400. 537. Ashton-Rickardt PG, Van Kaer L, Schumacher TN, Ploegh HL, Tonegawa S: Peptide contributes to the specificity of positive + selection of CD8 T cells in the thymus. Cell 1993, 73:1041-1049. 538. Ljunggren HG, Van Kaer L, Ploegh HL, Tonegawa S: Altered natural killer cell repertoire in Tap-1 mutant mice. Proc Natl Acad Sci USA 1994, 91:6520-6524. 539. Aldrich CJ, Ljunggren HG, Van Kaer L, Ashton-Rickardt PG, Tonegawa S, Forman J: Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice. Proc Natl Acad Sci USA 1994, 91:6525-6528. 540. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, et al.: Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 1993, 90:2375-2379. 541. Wei S, Episkopou V, Piantedosi R, Maeda S, Shimada K, Gottesman ME, et al.: Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. I Biol Chem 1995, 270:866-870.
KNOCKOUTS 542. Palha A, Episkopou V, Maeda S, Shimada K, Gottesman ME, Saraiva MJM: Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 1994, 269:33135-33139. 543.Smeyne RI, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, et al.: Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 1994, 368: 246-249. 544. Klein R, Smeyne RJ, Wurst W, Long LK, Auerbach BA, Joyner AL, et
al.: Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 1993, 75:113-122. 545. Klein R, Silos SI, Smeyne R, Lira SA, Brambilla R, Bryant S, et al.:
881
558. Shimamura K, Hirano S, McMahon AP, Takeichi M: Wnt-1-depen-
dent regulation of local E-cadherin and alphaN-catenin expression in the embryonic mouse brain. Development 1994, 120:2225-2234. 559. Takada S, Stark KL, Shea MJ, Vassileva GC,McMahon JA, McMahon
AP: Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes Dev 1994, 8:174-189. 560. Stark K, Vainio S, Vassileva G, McMahon AP: Epithelial transforma-
tion of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 1994, 372:679-683.
561. Parr BA, McMahon AP: Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes of mouse limb. Nature 1995, 374:350-353.
Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements. Nature 1994,
562. Stein PL, Vogel H, Soriano P: Combined deficiencies of Src, Fyn, and
368:249-251. 546. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, et al.:
563. Schilham MW, Fung LWP, Rahemtulla A, Kuendig T, Zhang L, Potter J,
Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993, 364:798-802. 547. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K,
Yes tyrosine kinases in mutant mice. Genes Dev 1994, 8:1999-2007. et al.: Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8. ur Immunol 1993, 23: 1299-1304. 564. Yeung R, Penninger
JM,
Kndig TM, Law Y,
Yamamoto
K,
Shahinian A, et al.: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993, 73:457-467.
Kamikawaji N, et al.: Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8deficient background: Reconstitution of phenotype and humanrestricted function. J Exp Med 1994, 180:1911-1920.
548. Mackay F, Rothe J, Bluethmann H, Loetscher H, Lesslauer W: Differ-
565. Condie BG, Capecchi MR: Mice with targeted disruptions in the
ential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation. J Immunol
paralogous genes hoxa-3 and hoxd-3 reveal synergistic interactions.
1994, 153:5274-5284. 549. Erickson SL, De Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S,
Gillett N, et al.: Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994, 372:560-563. 550. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S,
Nature 1994, 370:304-307. 566. Shikone T, Matzuk MM, Perlas E, Finegold MI, Lewis KA, Vale W,
et al.: Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: The role of activin as an autocrine growth factor. Mol Endocrinol 1994, 8:983 995. 567. Sadlack B, Kuhn R, Schorle H, Rajewsky K, Muller W, Horak
:
et al.: Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994, 264:703-707.
Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur] Immunol 1994, 24:281-284.
551. Gurtner GC, Davis V, Li H, McCoy Ml, Sharpe A, Cybulsky MI: Tar-
568. Grusby M), Auchincloss HJ, Lee R, Johnson RS, Spencer JP, Zijlstra M,
geted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev 1995, 9:1-14. 552. Zmuidzinas A, Fischer KD, Lira SA, Forrester L, Bryant S, Bernstein
A, et al.: The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J 1995, 14:1-11. 553. Colucci GE, Portier MM, Dunia I, Paulin D, Pournin S, Babinet C:
Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 1994, 79:679-694. 554. Kreidberg JA, Sariola H, Loring iM, Maeda M, Pelletier J, Housman D,
et al.: WT-1 is required for early kidney development. Cell 1993, 74:679-691. 555. McMahon AP, Bradley A: The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 1990, 62:1073-1085. 556. Thomas KR, Capecchi MR: Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 1990, 346:847-850. 557. McMahon AP, Joyner AL, Bradley A, McMahon JA: The midbrain-
hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum. Cell 1992, 69:581 595.
et al.: Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci USA 1993, 90:3913-3917. 569. Dierich A, Chan SH, Benoist C, Mathis D: Graft rejection by T cells
not restricted by conventional major histocompatibility complex molecules. EurJ Immunol 1993, 23:2725-2728. 570. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH,
Jaenisch R: MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993, 75:1351-1359. 571. Lohnes D, Mark M, Mendelsohn C, Doll
P, Dierich A, CGorry P, et al.:
Function of the retinoic acid receptors (RARs) during development (I). Development 1994, 120:2723-2748. 572. Mendelsohn C, Lohnes D, D6cimo D, Lufkin T, LeMeur M, Chain-
bon P, et al.: Function of the retinoic acid receptors (RARs) during development (11).Development 1994, 120: 2749-2771.
KNOCKOUTS
Targeting the mouse genome: a compendium of knockouts (part III)
© Current Biology 1995, Vol 5 No 8
873
874
Current Biology 1995, Vol 5 No 8
KNOCKOUTS
875
876
Current Biology 1995, Vol 5 No 8
KNOCKOUTS
877
878
Current Biology 1995, Vol 5 No 8 References 398. Cremer H, Lange R, Christoph A, Plomann M, Vopper G, Roes J, et al.: Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature
422.
1994, 367:455-459.
399. Tomasiewicz H, Ono K, Yee D, Thompson C, Goridis C, Rutishauser U, et al.: Genetic deletion of a neural cell adhesion molecule variant (N-CAM-180) produces distinct defects in the central nervous system. Neuron 1993, 11:1163-1174.
400. Brannan Cl, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, et a.: Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994, 8:1019-1029. 401. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumour predisposition in mice heterozygous for a targeted mutation in Nfl. Nature Genet 1994, 7:353-361. 402. Ernfors P, Lee KF, Kucera J, Jaenisch R: Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994, 77:503-512. 403. Tessarollo L, Vogel KS, Palko ME, Reid SW, Parada LF: Targeted
mutation in the neurotrophin-3 gene results in loss of muscle sensory neurons. Proc Natl Acad Sci USA 1994, 91:11844-11848. 404. Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF: Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994, 369:658-661. 405. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, et al.: Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995, 80:353-361.
406. Sha WC, Liou H-C, Tuomanen El, Baltimore D: Targeted disruption of the p50 subunit of NF-kappaB leads to multifocal defects in immune responses. Cell 1995, 80:321-330. 407. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993, 75:1273-1286. 408. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994, 265:1883-1885. 409. O'Dell Ti, Huang PL, Dawson TM, Dinerman JL, Snyder SH, Kandel ER, et a.: Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 1994, 265: 542-546. 410. Swiatek PJ,Lindsell CE, del AFF, Weinmaster G, Gridley T: Notch1 is essential for postimplantation development in mice. Genes Dev 1994, 8:707-719. 411. Corcoran LM, Karvelas M, Nossal GJ, Ye ZS, Jacks T, Baltimore D: Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev 1993, 7:570-582.
412. Pollock JD, Williams DA, Gifford MAC, Li LL, Du X, Fisherman Ji,et al.: Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nature Genet 1995, 9:202-209. 413. Giese KP, Martini R, Lemke G, Soriano P, Schachner M: Mouse PO gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 1992, 71:565-576.
414. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CAJ, Butel JS, et al.: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356:
423. 424.
425. 426. 427. 428. 429. 430. 431.
432. 433.
434.
435. 436. 437. 438. 439.
215-221.
415. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992, 70:923-935. 416. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, et al.: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993, 362:849-852. 417. Harvey M, McArthur MJ, Montgomery CAJ, Butel JS, Bradley A, Donehower LA: Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet 1993, 5:225-229. 418. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, et al.: In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 1993, 8:2457-2467. 419. Hursting SD, Perkins SN, Phang JM: Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc Natl Acad Sci USA 1994, 91:7036-7040. 420. Kemp Ci, Donehower LA, Bradley A, Balmain A: Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 1993, 74:813-822.
421. Kemp CJ, Wheldon T, Balmain A: p53-deficient mice are extremely
440. 441. 442.
443.
444. 445.
susceptible to radiation-induced tumorigenesis. Nature Genet 1994, 8:66-69. Lee JM, Abrahamson J, Kandel R, Donehower LA, Bernstein A: Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 1994, 9: 3731-3736. Lotem J, Sachs L: Hematopoietic cells from mice deficient in wildtype p53 are more resistant to induction of apoptosis by some agents. Blood 1993, 82:1092-1096. Berges RR, Furuya Y, Remington L, English HF, Jacks T, Isaacs JT: Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 1993, 90:8910-8914. Kastan MB, Zhan Q, El-Deiry WS, Carrier F,Jacks T, Walsh WV, et a.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 isdefective inataxia-telangiectasia. Cell 1992, 71: 587-597. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993, 74:957-967. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993, 362:847-849. Lowe SW, Jacks T, Housman DE, Ruley HE: Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA 1994, 91:2026-2030. Symonds H, Krall L, Remington L, Saenz RM, Lowe S, Jacks T, et al.: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994, 78:703-711. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994, 371:72-74. Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH: p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 1994, 9:1767-1773. Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SE,etal.: Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 1994, 9:603-609. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, et al.: Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 1994, 8:277-289. Lowin B, Beermann F, Schmidt A, Tschopp J: A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994, 91: 11571-11575. Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, et al.: Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA 1994, 91:10854-10858. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ,etal.: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994, 369:31-37. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994, 370:650-652. Laird PW, van der Lugt NMT, Clarke A, Domen J, Linders K, McWhir J, et al.: In vivo analysis of Pim-1 deficiency. Nucleic Acids Res 1993, 21:4750-4755. Domen J, van der Lugt NMT, Acton D, Laird PW, Linders K, Berns A: Pim-1 levels determine the size of early B lymphoid compartments in bone marrow. J Exp Med 1993, 178:1665-1673. Domen J, van der Lugt NMT, Laird PW, Saris CJ, Berns A: Analysis of Pim-1 function in mutant mice. Leukemia 1993, 7 (suppl 2): 108-112. Domen J, van der Lugt NMT, Laird PW, Saris CJ, Clarke AR, Hooper ML, et al.: Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells. Blood 1993, 82:1445-1452. Carmeliet P, Kieckens L, Schoonjans L, Ream B, van NA, Prendergast G, et al.: Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest 1993, 92:2746-2755. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van dOJJ, De MM, et al.: Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. Clin Invest 1993, 92:2756-2760. Leveen P, Pekny M, Gebre MS, Swolin B, Larsson E, Betsholtz C: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 1994, 8:1875-1887. Soriano P: Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 1994, 8: 1888-1896.
KNOCKOUTS 446. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al.: Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992, 356:577-582. 447. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al.: Mice devoid of PrP are resistant to scrapie. Cell 1993, 73: 1339-1347. 448. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, et al.: Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 1993, 90:10608-10612. 449. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, et al.: Prion protein is necessary for normal synaptic function. Nature 1994, 370:295-297. 450. Weissmann C, Bueler H, Fischer M, Aguet M: Role of the PrP gene in transmissible spongiform encephalopathies. Intervirology 1993, 35:164-175. 451. Weissmann C, Bueler H, Fischer M, Sauer A, Aguet M: Susceptibility to scrapie in mice is dependent on PrPC. Philos Trans R Soc Lond [Bioll] 1994, 343:431-433. 452. Sailer A, Bueler H, Fischer M, Aguzzi A, Weissmann C: No propagation of prions in mice devoid of PrP. Cell 1994, 77:967-968. 453. Whittington MA, Sidle KCL, Gowland I, Meads J, Hill AF, Palmer MS, et al.: Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nature Genet 1995, 9:197-201. 454. Abeliovich A, Paylor R, Chen C, Kim JJ,Wehner JM, Tonegawa S: PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning. Cell 1993, 75:1263-1271. 455. Abeliovich A, Chen C, Goda Y, Silva A], Stevens CF, Tonegawa S: Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell 1993, 75:1253-1262. 456. Boison D, Stoffel W: Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci USA 1994, 91:11709-11713. 457. Scott EW, Simon MC, Anastasi J, Singh H: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994, 265:1573-1577. 458. Geppert M, Bolshakov VY, Siegelbaum SA, Takei K, De CP, Hammer RE, et al.: The role of Rab3A in neurotransmitter release. Nature 1994, 369:493-497. 459. Umanoff H, Edelmann W, Pellicer A, Kucherlapati R: The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci USA 1995, 92:1 709-1713. 460. Warren AJ, Colledge WH, Carlton MB, Evans Mi, Smith AJ, Rabbitts TH: The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 1994, 78:45-57. 461. Mombaerts P,-lacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877. 462. Spanopoulou E, Roman CA, Corcoran LM, Schlissel MS, Silver DP, Nemazee D, et al.: Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev 1994, 8:1030-1042. 463. Levelt CN, Mombaerts P, Iglesias A, Tonegawa S, Eichmann K: Restoration of early thymocyte differentiation in T-cell receptor betachain-deficient mutant mice by transmembrane signaling through CD3 epsilon. Proc Natl Acad Sci USA 1993, 90:11401-11405. 464. Lafaille JJ,Nagashima K, Katsuki M, Tonegawa S: High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994, 78:399-408. 465. Mombaerts P,Clarke AR, Rudnicki MA, lacomini J, Itohara S, Lafaille JJ, et al.: Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages [published erratum appears in Nature 1992; 360:4911. Nature 1992, 360:225-231. 466. Godfrey DI, Kennedy J, Mombaerts P, Tonegawa S, Zlotnik A: Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8- thymocyte differentiation. J Immunol 1994, 152:4783-4792. 467. Jacobs H, Vandeputte D, Tolkamp L, de Vries E, Borst J, Berns A: CD3 components at the surface of pro-T cells can mediate pre-T cell development in vivo. Eurl Immunol 1994, 24:934-939. 468. Shinkai Y, Rathbun C, Lam KP, Oltz EM, Stewart V, Mendelsohn M, et al.: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867. 469. Chen J, Lansford R, Stewart V, Young F, Alt FW: RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. Proc Natl Acad Sci USA 1993, 90:4528-4532. 470. Rodewald HR, Awad K, Moingeon P, D'Adamio L, Rabinowitz D, Shinkai Y, et al.: Fc gamma RII/111 and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes:
in vivo developmental kinetics and T cell receptor beta chain rearrangement status. J Exp Med 1993, 177:1079-1092. 471. Bottaro A, Lansford R, Xu L, Zhang J, Rothman P, Alt FW: S region transcription per se promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO J 1994, 13:665-674. 472. Shinkai Y, Koyasu S, Nakayama K, Murphy KM, Loh DY, Reinherz EL, et al.: Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science 1993, 259:822-825. 473. Castigli E,Alt FW, Davidson L, Bottaro A, Mizoguchi E,Bhan AK, et al.: CD40-deficient mice generated by recombination-activating gene-2deficient blastocyst complementation. Proc Natl Acad Sci USA 1994, 91:12135-12139. 474. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck R-P, et al.: Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappaB/Rel family. Cell 1995, 80:331-340. 475. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, et al.: Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995, 373:531-536. 476. Schuchardt A, D'Agati V, Larsson BL, Costantini F, Pachnis V: Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994, 367:380-383. 477. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA: Effects of an Rb mutation in the mouse. Nature 1992, 359: 295-300. 478. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, et al.: Requirement for a functional Rb-i gene in murine development. Nature 1992, 359:328-330. 479. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, et al.: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992, 359:288-294. 480. Hu N, Gutsmann A, Herbert DC, Bradley A, Lee WH, Lee EY: Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 1994, 9:1021-1027. 481. Lee EY, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, et a.: Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev 1994, 8:2008-2021. 482. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub MP, et al.: High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci USA 1993, 90:7225-7229. 483. Li E, Sucov HM, Lee KF, Evans RM, aenisch R: Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. Proc Natl Acad Sci USA 1993, 90:1590-1594. 484. Mendelsohn C, Mark M, Dolle P, Dierich A, Gaub MP, Krust A, et al.: Retinoic acid receptor beta2 (RARbeta2) null mutant mice appear normal. Dev Biol 1994, 166:246-258. 485. Lohnes D, Kastner P Dierich A, Mark M, LeMeur M, Chambon P: Function of retinoic acid receptor gamma in the mouse. Cell 1993, 73:643-658. 486. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, Evans RM: RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 1994, 8:1007-1018. 487. Kastner P,Grondona JM, Mark M, Gansmuller A, LeMeur M, Decimo D, et a: Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 1994, 78:987-1003. 488. Takeshima H, lino M, Takekura H, Nishi M, Kuno J, Minowa O, et al.: Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 1994, 369:556-559. 489. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD: Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993, 74:541-554. 490. Saudou F,Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L, et al.: Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 1994, 265:1875-1878. 491. Luo X, Ikeda Y, Parker KL: A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490. 492. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, Nachtigal MW, et al.: The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 1994, 8:2302-2312. 493. Jung S, Rajewsky K, Radbruch A: Shutdown of class switch recombination by deletion of a switch region control element. Science 1993, 259:984-987. 494. Soriano P, Montgomery C, Geske R, Bradley A: Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991, 64:693-702.
879
880
Current Biology 1995, Vol 5 No 8 495. Thomas JE,Soriano P, Brugge JS: Phosphorylation of c-Src on tyrosine 527 by another protein tyrosine kinase. Science 1991, 254: 568-571. 496. Boyce BF, Chen H, Soriano P, Mundy GR: Histomorphometric and immunocytochemical studies of src-related osteopetrosis. Bone 1993, 14:335-340. 497. Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P: Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA 1993, 90:4485-4489. 498. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ: Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 1994, 8:23-32. 499. Thomas JE, Aguzzi A, Soriano P, Wagner EF, Brugge IS: Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. Oncogene 1993, 8:2521-2529. 500. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR: Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 1992, 90:1622-1627. 501. Kohmura N, Yagi T, Tomooka Y, Oyanagi M, Kominami R,Takeda N, et al.: A novel nonreceptor tyrosine kinase, Srm: Cloning and targeted disruption. Mol Cell Biol 1994, 14:6915-6925. 502. Rosahl TW, Geppert M, Spillane D, Herz J, Hammer RE, Malenka RC, et al.: Short-term synaptic plasticity is altered in mice lacking synapsin I. Cell 1993, 75:661-670. 503. Geppert M, Goda Y, Hammer RE, Li C, Rosahl TW, Stevens CF, et 2 al.: Synaptotagmin I:a major Ca +sensor for transmitter release at a central synapse. Cell 1994, 79:717-727. 504. Verbeek S, Izon D, Hofhuis F, Robanus-Maandag E, te Riele H, van de Wetering M, et al.: An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 1995, 374:70-74. 505. Philpott KL, Viney JL, Kay G, Rastan S, Gardiner EM, Chae S, et al.: Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. Science 1992, 256:1448-1452. 506. Mombaerts P, Arnoldi , Russ F, Tonegawa S, Kaufmann SH: Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature 1993, 365:53-56. 507. Tsuji M, Mombaerts P, Lefrancois L, Nussenzweig RS, Zavala F, Tonegawa S: Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. Proc Natl Acad Sci USA 1994, 91:345-349. 508. Wen L, Roberts SJ,Viney JL, Wong FS,Mallick C, Findly RC, et al.: Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cells. Nature 1994, 369:654-658. 509. Viney JL, Dianda L, Roberts SJ,Wen L, Mallick CA, Hayday AC, et al.: Lymphocyte proliferation in mice congenitally deficient in T+ cell receptor alphabeta cells. Proc Natl Acad Sci USA 1994, 91:11948-11952. 510. Itohara S, Mombaerts P, Lafaille J, lacomini J, Nelson A, Clarke AR, et al.: T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell 1993, 72:337-348. 511. Ohno H, Goto S, Taki S, Shirasawa T, Nakano H, Miyatake S, et al.: Targeted disruption of the CD3 eta locus causes high lethality in mice: modulation of Oct-1 transcription on the opposite strand. EMBOJ 1994, 13:1157-11565. 512. Koyasu S, Hussey RE, Clayton LK, Lerner A, Pedersen R, Delany HP, et al.: Targeted disruption within the CD3 zeta/eta/phi/Oct-1 locus in mouse. EMBOJ 1994, 13:784-797. 513. Love PE, Shores EW, Johnson MD, Tremblay ML, Lee EJ,Grinberg A, et al.: T cell development in mice that lack the zeta chain of the T cell antigen receptor complex. Science 1993, 261:918-921. 514. Liu C-P, Ueda R, She I, Sancho J, Wang B, Weddell G, et a/.: Abnormal T cell development in CD3-zeta-/- mutant mice and identification of a novel T cell population in the intestine. EMBO 1993, 12:4863-4875. 515. Ohno H, Aoe T, Taki S, Kitamura D, Ishida Y, Rajewsky K, et al.: Developmental and functional impairment of T cells in mice lacking CD3 zeta chains. EMBOJ 1993, 12:4357-4366. 516. Shores EW, Huang K, Tran T, Lee E, Grinberg A, Love PE: Role of TCR zeta chain in T cell development and selection. Science 1994, 266:1047-1050. 517. Malissen M, Gillet A, Rocha B, Trucy , Vivier E, Boyer C, et al.: T cell development in mice lacking the CD3-zeta/eta gene. EMBO J 1993, 12:4347-4355. 518. Shivdasani RA, Mayer EL, Orkin SH: Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature 1995, 373:432-434. 519. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, et al.: Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 1994, 369:488-491.
520. Dumont DJ, Gradwohl G, Fong GH, Purl MC, Gertsenstein M, Auerbach A, et al.: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994, 8: 1897-1909. 521. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S: Mice develop normally without tenascin. Genes Dev 1992, 6:1821-1831. 522. Steindler DA, Settles D, Erickson HP, Laywell ED, Yoshiki A, Faissner A, et al.: Tenascin knockout mice: barrels, boundary molecules, and glial scars. J Neurosci 1995, 15:1971-1983. 523. Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D: Mice lacking TdT: mature animals with an immature lymphocyte repertoire Published erratum appears in Science 1993; 262:1957]. Science 1993, 261:1175-1178. 524. Healy AM, Rayburn HB, Rosenberg RD, Weiler H: Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci USA 1995, 92:850-854. 525. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, et al.: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994, 368:419-424. 526. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, et a.: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993, 90:770-774. 527. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ,Yin M, et al.: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693 699. 528. Christ M, McCartney-Francis NL, Kulkarni AB, Ward IM, Mizel DE, Mackall CL, et al.: Immune dysregulation in TGF-beta 1-deficient mice. J Immunol 1994,153:1936-1946. 529. Geiser AG, Letterio J, Kulkarni AB, Karlsson S, Roberts AB, Sporn MB: Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc Natl Acad Sci USA 1993, 90:9944-9948. 530. Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, et al.: Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci USA 1993, 90:6076-6080. 531. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB: Maternal rescue of transforming growth factor-beta 1 null mice. Science 1994, 264:1936-1938. 532. Glick AB, Lee MM, Darwiche N, Kulkarni AB, Karlsson S, Yuspa SH: Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes Dev 1994, 8:2429-2440. 533. Hines KL, Kulkarni AB, McCarthy JB, Tian H, Ward JM, Christ M, et al.: Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc Natl Acad Si USA 1994, 91:5187-5191. 534. Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S: TAP1 mutant mice are deficient in antigen presentation, surface class I + molecules, and CD4-8 T cells. Cell 1992, 71:1205-1214. 535. Ashton-Rickardt PG, Bandeira A, Delaney JR, Van Kaer L, Pircher HP, Zinkernagel RM, et al.: Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994, 76:651-663. 536. Moriwaki S, Korn BS, Ichikawa Y, Van Kaer L, Tonegawa S: Amino acid substitutions in the floor of the putative antigen-binding site of H-2T22 affect recognition by a gamma delta T-cell receptor. Proc Natl Acad Sci USA 1993, 90:11396-11400. 537. Ashton-Rickardt PG, Van Kaer L, Schumacher TN, Ploegh HL, Tonegawa S: Peptide contributes to the specificity of positive + selection of CD8 T cells in the thymus. Cell 1993, 73:1041-1049. 538. Ljunggren HG, Van Kaer L, Ploegh HL, Tonegawa S: Altered natural killer cell repertoire in Tap-1 mutant mice. Proc Natl Acad Sci USA 1994, 91:6520-6524. 539. Aldrich CJ, Ljunggren HG, Van Kaer L, Ashton-Rickardt PG, Tonegawa S, Forman J: Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice. Proc Natl Acad Sci USA 1994, 91:6525-6528. 540. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, et al.: Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 1993, 90:2375-2379. 541. Wei S, Episkopou V, Piantedosi R, Maeda S, Shimada K, Gottesman ME, et al.: Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. I Biol Chem 1995, 270:866-870.
KNOCKOUTS 542. Palha A, Episkopou V, Maeda S, Shimada K, Gottesman ME, Saraiva MJM: Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 1994, 269:33135-33139. 543.Smeyne RI, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, et al.: Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 1994, 368: 246-249. 544. Klein R, Smeyne RJ, Wurst W, Long LK, Auerbach BA, Joyner AL, et
al.: Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 1993, 75:113-122. 545. Klein R, Silos SI, Smeyne R, Lira SA, Brambilla R, Bryant S, et al.:
881
558. Shimamura K, Hirano S, McMahon AP, Takeichi M: Wnt-1-depen-
dent regulation of local E-cadherin and alphaN-catenin expression in the embryonic mouse brain. Development 1994, 120:2225-2234. 559. Takada S, Stark KL, Shea MJ, Vassileva GC,McMahon JA, McMahon
AP: Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes Dev 1994, 8:174-189. 560. Stark K, Vainio S, Vassileva G, McMahon AP: Epithelial transforma-
tion of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 1994, 372:679-683.
561. Parr BA, McMahon AP: Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes of mouse limb. Nature 1995, 374:350-353.
Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements. Nature 1994,
562. Stein PL, Vogel H, Soriano P: Combined deficiencies of Src, Fyn, and
368:249-251. 546. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, et al.:
563. Schilham MW, Fung LWP, Rahemtulla A, Kuendig T, Zhang L, Potter J,
Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993, 364:798-802. 547. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K,
Yes tyrosine kinases in mutant mice. Genes Dev 1994, 8:1999-2007. et al.: Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8. ur Immunol 1993, 23: 1299-1304. 564. Yeung R, Penninger
JM,
Kndig TM, Law Y,
Yamamoto
K,
Shahinian A, et al.: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993, 73:457-467.
Kamikawaji N, et al.: Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8deficient background: Reconstitution of phenotype and humanrestricted function. J Exp Med 1994, 180:1911-1920.
548. Mackay F, Rothe J, Bluethmann H, Loetscher H, Lesslauer W: Differ-
565. Condie BG, Capecchi MR: Mice with targeted disruptions in the
ential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation. J Immunol
paralogous genes hoxa-3 and hoxd-3 reveal synergistic interactions.
1994, 153:5274-5284. 549. Erickson SL, De Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S,
Gillett N, et al.: Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994, 372:560-563. 550. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S,
Nature 1994, 370:304-307. 566. Shikone T, Matzuk MM, Perlas E, Finegold MI, Lewis KA, Vale W,
et al.: Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: The role of activin as an autocrine growth factor. Mol Endocrinol 1994, 8:983 995. 567. Sadlack B, Kuhn R, Schorle H, Rajewsky K, Muller W, Horak
:
et al.: Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994, 264:703-707.
Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur] Immunol 1994, 24:281-284.
551. Gurtner GC, Davis V, Li H, McCoy Ml, Sharpe A, Cybulsky MI: Tar-
568. Grusby M), Auchincloss HJ, Lee R, Johnson RS, Spencer JP, Zijlstra M,
geted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev 1995, 9:1-14. 552. Zmuidzinas A, Fischer KD, Lira SA, Forrester L, Bryant S, Bernstein
A, et al.: The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J 1995, 14:1-11. 553. Colucci GE, Portier MM, Dunia I, Paulin D, Pournin S, Babinet C:
Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 1994, 79:679-694. 554. Kreidberg JA, Sariola H, Loring iM, Maeda M, Pelletier J, Housman D,
et al.: WT-1 is required for early kidney development. Cell 1993, 74:679-691. 555. McMahon AP, Bradley A: The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 1990, 62:1073-1085. 556. Thomas KR, Capecchi MR: Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 1990, 346:847-850. 557. McMahon AP, Joyner AL, Bradley A, McMahon JA: The midbrain-
hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum. Cell 1992, 69:581 595.
et al.: Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci USA 1993, 90:3913-3917. 569. Dierich A, Chan SH, Benoist C, Mathis D: Graft rejection by T cells
not restricted by conventional major histocompatibility complex molecules. EurJ Immunol 1993, 23:2725-2728. 570. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH,
Jaenisch R: MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993, 75:1351-1359. 571. Lohnes D, Mark M, Mendelsohn C, Doll
P, Dierich A, CGorry P, et al.:
Function of the retinoic acid receptors (RARs) during development (I). Development 1994, 120:2723-2748. 572. Mendelsohn C, Lohnes D, D6cimo D, Lufkin T, LeMeur M, Chain-
bon P, et al.: Function of the retinoic acid receptors (RARs) during development (11).Development 1994, 120: 2749-2771.